Does machine learning based on biomarker profiles identify distinct subgroups of patients with HFpEF?
Machine learning based on biomarker profiles can identify distinct pathophysiological subgroups in patients with HFpEF.
Unsupervised cluster analysis based on biomarker profiles identified mutually exclusive subgroups of patients with HFpEF with distinct biomarker profiles, clinical characteristics and outcomes, suggesting different underlying pathophysiological pathways.
Woolley et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: